Jan 14, 2025 · Tempus One, which initially launched in 2023, provides both physicians and researchers AI-enabled services that leverage generative AI to propel privacy-enabled, data-driven decision support in the clinic while simultaneously advancing research to bring new drugs to …

Feb 25, 2025 · Specializing in AI-driven precision medicine, Tempus integrates vast amounts of clinical and molecular data to provide tailored treatment options. By leveraging machine learning and high-throughput genomic sequencing, Tempus is pushing the boundaries of oncology, cardiology, and genetic disease management.

Mar 11, 2025 · Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has acquired Deep 6 AI, a leading AI-powered precision research platform for healthcare organizations and life sciences companies. Deep 6 AI enables healthcare organizations to de-risk clinical trials, accelerate recruitment, and generate … Continued

Jul 14, 2024 · Tempus AI's suite of AI-enabled tests, including Homologous Recombination Deficiency (HRD) and Tumor Origin (TO), is leveraging sequencing data to enhance clinical utility. The new PLA code for PurISTSM could pave the way for reimbursement for algorithm-driven insights, establishing a new paradigm in AI-driven healthcare.

Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, [5] for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM." [6][7]

Jan 23, 2025 · Tempus develops algorithms like the Tumor Origin Test and the ECG-AF algorithm, using AI to increase diagnostic precision for diseases like cancer and atrial fibrillation.

Jan 6, 2025 · At Tempus, we’re at the forefront of this revolution, integrating generative AI into our suite of products — including our AI-enabled clinical assistant, Tempus One, as well as our suite of AI applications, Olivia, Lens and others — to deliver unparalleled value.

Mar 17, 2025 · Deep 6 AI joins Tempus with AI-powered software that matches patients to clinical trials by mining real-time structured and unstructured electronic medical record (EMR) data across a broad ecosystem.

Jun 6, 2024 · Tempus AI is revolutionizing healthcare with its AI-powered platform for precision medicine. Learn how it works, its impact, and future potential.

Mar 18, 2025 · Tempus AI's financials have significantly improved, with positive cash flow expected next quarter. Read why TEM stock is a Strong Buy.